The Association of Cancer Care Centers (ACCC) today released the following statement in support of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842/S. 339) (“MCED Act”), which would create a meaningful pathway for seniors to have access to the newest transformational tools in cancer detection.
“Cancer centers are at the heart of tremendous advances in cancer care, and we know that detecting cancer early makes all the difference in cancer outcomes. Until recently, we have only been able to screen for five cancers, leaving too many cancers undetected until they have spread to other parts of the body and are more difficult to treat,” said Meagan O’Neill, ACCC Executive Director. This is now changing thanks to multi-cancer early detection, but it is incumbent upon Congress to make these tools accessible to Medicare beneficiaries. This week Congress has the opportunity to unleash a new era in combating cancer by voting on the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842/S. 339). Congress has repeatedly acted to ensure patients have access to innovative tools to combat cancer and stands ready to do so again this week. We will continue to support Congress in those efforts, beginning with the passage of this bill for patients.
About the Association of Cancer Care Centers
The Association of Cancer Care Centers (ACCC) is a leading education and advocacy organization dedicated to serving the cancer care community. ACCC is viewed as a well-established and highly respected organization within the oncology industry, built on our 50+ year history of serving cancer care teams and the patients they support. ACCC is differentiated by our unique multidisciplinary focus and wide-reaching nationwide footprint. The current membership base encompasses 45,000+ cancer care professionals from more than 1,700 different member organizations. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve, so has ACCC. The organization continually adapts its resources to meet the changing needs of the entire oncology care team.
For more information, visit accc-cancer.org | Follow us on social | Read our ACCCBuzz blog | Listen to our CANCER BUZZ podcast
October 30, 2025
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
